Dr. Reddy's releases generic Oracea
Generic Oracea is indicated for the treatment of inflammatory lesions of rosacea in adult patients.
Dr. Reddy's is launching Doxycycline Capsules, 40 mg, which is the generic of Galderma Holdings, S.A.’s Oracea.
Generic Oracea is indicated for the treatment of inflammatory lesions (papules and pustules) of rosacea in adult patients.
[Read more: Dr. Reddy's acquires MenoLabs from Amyris]
Dr. Reddy’s Doxycycline Capsules, 40 mg, are supplied in bottle counts of 30.
Each capsule contains: 26 mg immediate-release pellets and 14 mg delayed-release pellets equivalent to 40 mg of anhydrous doxycycline.
[Read more: Dr. Reddy’s intros Avastin biosimilar in the U.K.]